236 related articles for article (PubMed ID: 19647470)
1. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
[TBL] [Abstract][Full Text] [Related]
2. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
4. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
Ge F; Ding J; Liu Y; Lin H; Chang T
Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
8. Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes.
Süssmuth SD; Uttner I; Landwehrmeyer B; Pinkhardt EH; Brettschneider J; Petzold A; Kramer B; Schulz JB; Palm C; Otto M; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2010 Jul; 25(9):1284-8. PubMed ID: 20589870
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
Holmberg B; Johnels B; Blennow K; Rosengren L
Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
[TBL] [Abstract][Full Text] [Related]
11. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
12. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.
Abdo WF; Bloem BR; Van Geel WJ; Esselink RA; Verbeek MM
Neurobiol Aging; 2007 May; 28(5):742-7. PubMed ID: 16678934
[TBL] [Abstract][Full Text] [Related]
13. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
[TBL] [Abstract][Full Text] [Related]
14. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
[TBL] [Abstract][Full Text] [Related]
15. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
16. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
[TBL] [Abstract][Full Text] [Related]
18. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
